Search Results - "Dugyala, Raju"

Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants by Vadrevu, Krishna Mohan, Ganneru, Brunda, Reddy, Siddharth, Jogdand, Harsh, Raju, Dugyala, Sapkal, Gajanan, Yadav, Pragya, Reddy, Prabhakar, Verma, Savita, Singh, Chandramani, Redkar, Sagar Vivek, Gillurkar, Chandra Sekhar, Kushwaha, Jitendra Singh, Mohapatra, Satyajit, Bhate, Amit, Rai, Sanjay Kumar, Ella, Raches, Abraham, Priya, Prasad, Sai, Ella, Krishna

“…This is a comprehensive report on immunogenicity of COVAXIN ® booster dose against ancestral and Variants of Concern (VOCs) up to 12 months. It is well known…”
Get full text

Safety, immunogenicity and non-interference of concomitant Typhoid Vi capsular polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV®) and measles or measles-mumps-rubella vaccines in 8-9 months-old Indian children by Vadrevu, Krishna Mohan, Dugyala, Raju, Mahantashetti, Niranjana Shamulinga, Khalatkar, Vasant, Murthy, Krishna, Mogre, Sandeep, Mitra, Monjori

“…We evaluated safety, reactogenicity, and immunogenicity when the WHO-prequalified single-dose Typhoid Vi-polysaccharide conjugate vaccine, Typbar-TCV®, was…”
Get full text

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial by Ella, Raches, Reddy, Siddharth, Jogdand, Harsh, Sarangi, Vamshi, Ganneru, Brunda, Prasad, Sai, Das, Dipankar, Raju, Dugyala, Praturi, Usha, Sapkal, Gajanan, Yadav, Pragya, Reddy, Prabhakar, Verma, Savita, Singh, Chandramani, Redkar, Sagar Vivek, Gillurkar, Chandra Sekhar, Kushwaha, Jitendra Singh, Mohapatra, Satyajit, Bhate, Amit, Rai, Sanjay, Panda, Samiran, Abraham, Priya, Gupta, Nivedita, Ella, Krishna, Bhargava, Balram, Vadrevu, Krishna Mohan

“…BBV152 is a whole-virion inactivated SARS-CoV-2 vaccine (3 μg or 6 μg) formulated with a toll-like receptor 7/8 agonist molecule (IMDG) adsorbed to alum…”
Get full text

Persisting antibody responses to Vi polysaccharide–tetanus toxoid conjugate (Typbar TCV®) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination by Vadrevu, Krishna Mohan, Raju, Dugyala, Rani, Sandhya, Reddy, Siddharth, Sarangi, Vamshi, Ella, Raches, Javvaji, Bhuvaneswara, Mahantshetty, Niranjana S., Battu, Sudhakar, Levine, Myron M.

“…Serum IgG anti-Vi titers attained by 327 children 6–23 months of age immunized with Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar TCV®), of whom…”
Get full text

Proximate, mineral composition and antioxidant activity of traditional small millets cultivated and consumed in Rayalaseema region of south India by Vali Pasha, Kotwal, Ratnavathi, Chamarthy Venkata, Ajani, Jayanna, Raju, Dugyala, Manoj Kumar, Sriramoju, Beedu, Sashidhar Rao

“…BACKGROUND Millets are a diverse group of small seeded grasses, widely grown around the world as cereal foods. This communication details the proximate,…”
Get full text

Biogenic green synthesis of monodispersed gum kondagogu (Cochlospermum gossypium) iron nanocomposite material and its application in germination and growth of mung bean (Vigna radiata) as a plant model by Raju, Dugyala, Mehta, Urmil J, Beedu, Sashidhar Rao

“…An eco-friendly green and one-pot synthesis of highly monodispersed iron (Fe) nanoparticles (NPs) by using a natural biopolymer, gum kondagogu (GK) as reducing…”
Get full text

Phytosynthesis of intracellular and extracellular gold nanoparticles by living peanut plant (Arachis hypogaea L.) by Raju, Dugyala, Mehta, Urmil J., Ahmad, Absar

“…Inorganic nanomaterials of different chemical compositions are conventionally synthesized under harsh environments such as extremes of temperature, pressure,…”
Get full text

Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies by Rigsby, Peter, Beamish, Emma, Hockley, Jason, Atkinson, Eleanor, Hitri, Krisztina, Jones, Elizabeth, Yang, Jae Seung, Qadri, Firdausi, Bachtiar, Novilia S., Elias, Sean C., Goel, Akshay, Mishra, Ravipratapnarayan, Dugyala, Raju, Pasetti, Marcela F., Meiring, James E., Mbewe, Maurice, Gordon, Melita A., Pollard, Andrew J., Logan, Alastair, Rijpkema, Sjoerd

“…Typhoid vaccines based on protein-conjugated capsular Vi polysaccharide (TCVs) prevent typhoid in infants and young children. Analysis of the serum anti-Vi IgG…”
Get full text